Endpoints News
"Genentech and Biogen roll the dice on an upstart biotech with a new siRNA approach — going...
In the news
Nature Biotechnology
"Two new startups, Triplet Therapeutics and Atalanta Therapeutics, are pushing to bring genetic medicine to patients with...
Presentations & publications
2020
Davidson, BL. Doubling down on siRNAs in the brain. Nat Biotechnol. 2019 Aug;37(8):865-866. doi: 10.1038/s41587-019-0204-1. doi:10.1038/s41587-019-0204-1 COPY READ MORE
2019
Godinho, BDMC, Khvorova, A. The era of RNA interference medicines: The clinical landscape of synthetic gene silencing drugs. Saude & Technologia. 2019;21:5-17. doi:10.25758/set.2227 READ MORE
Alterman JF, Godinho BMDC, Hassler MR, et al. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system. Nat Biotechnol. 2019 Aug;37(8):884-894 . doi:10.1038/s41587-019-0205-0 READ MORE
2018
Hassler MR, Turanov AA, Alterman JF, et al. Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo. Nucleic Acids Res. 2018;46(5):2185–2196. doi:10.1093/nar/gky037 READ MORE
Media contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
617-903-8783